ESC: Kerendia Hits In Heart Failure, But Usage Unclear
Bayer’s mineralocorticoid receptor antagonist is effective in heart failure with mildly reduced or preserved ejection fraction – but should it be used instead of SGLT2s, or on top of them?
Bayer’s mineralocorticoid receptor antagonist is effective in heart failure with mildly reduced or preserved ejection fraction – but should it be used instead of SGLT2s, or on top of them?